NCT04952545View on ClinicalTrials.gov

Study of ALXN2050 in Healthy Adult Participants of Japanese Descent

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 9, 2021

Primary Completion Date

September 7, 2021

Study Completion Date

September 7, 2021

Conditions
Healthy
Interventions
DRUG

ALXN2050

Oral tablet.

DRUG

Placebo

Oral tablet.

Trial Locations (1)

85283

Clinical Trial Site, Tempe

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY